Farmaforum Partnering Day 2025

18 Sept 2025 | Madrid, Spain

Register
Register
Register

ServiceUpdated on 14 August 2025

R&D of Generyc & Hybryd Drugs

Kseniya Tymko

Business Development Director at Pharmbiotest Poland Ltd

Grudziadz, Poland

About

From concept to market — we turn your ideas into successful products.
We offer a full-service approach to the development of generic and hybrid drugs, including:

  • Formulation development — over 40 ready-to-market formulations in our portfolio

  • Clinical trials — BA/BE/PK studies with in-house clinical and bioanalytical capabilities

  • Regulatory support — preparation and submission of documents to CTIS

  • Bioanalytical services — precise and fast LC-MS/MS analysis in compliance with EMA/FDA guidelines

Our expertise:

  • Cardiovascular and neurological drugs

  • Flexible service models: full-cycle development or standalone solutions tailored to your needs

With our experience and integrated facilities, we ensure speed, accuracy, and compliance — every step of the way.

Type

  • Development
  • Consulting

Applies to

  • Pharmaceutical industry
  • Laboratory industry
  • Health innovation

Organisation

Pharmbiotest Poland Ltd

Research organization

Grudziadz, Poland

Similar opportunities

  • Service

    Bioanalytical Services

    • Development
    • Laboratory industry
    • Pharmaceutical industry

    Kseniya Tymko

    Business Development Director at Pharmbiotest Poland Ltd

    Grudziadz, Poland

  • Service

    Phase I clinical trials

    • Others
    • Pharmaceutical industry

    Kseniya Tymko

    Business Development Director at Pharmbiotest Poland Ltd

    Grudziadz, Poland

  • Expertise

    ADVANCING PROTEIN DEGRADERS PROTACS or MOLECULAR GLUES

    Constantin TAMVAKOPOULOS

    Research Director Pharmacology, Center of Clinical, Experimental Surgery & Translational Research, at Pharmacolgy Tamvakopoulos Lab

    Athens, Greece